[Clinical experiences with the new spasmolytic drug Ayacan].
BEYER
H
H
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010276:Parasympatholytics
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics
Klinische Erfahrungen mit dem neuen Spasmolytikum Avacan.